These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 13861220)

  • 41. [The strength and metabolism of various antiepileptic drugs determined by testing against experimental epilepsy and determination of their differential toxicities].
    FROMMEL E; RADOUCO C; GOLD P; GREDER G; RADOUCO S; BURGERMEISTER-GUEX G; STRASSBERGER L; VALLETTE F; DUCOMMUN M
    Arch Int Pharmacodyn Ther; 1953 Jan; 92(3-4):368-407. PubMed ID: 13041305
    [No Abstract]   [Full Text] [Related]  

  • 42. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
    Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
    J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of quantitative structure-activity relationships and classification models for anticonvulsant activity of hydantoin analogues.
    Sutherland JJ; Weaver DF
    J Chem Inf Comput Sci; 2003; 43(3):1028-36. PubMed ID: 12767162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The metabolism of 3-methyl-5-ethyl-5-phenylhydantoin (mephenytoin) to 5-ethyl-5-phenylhydantoin (Nirvanol) in mice in relation to anticonvulsant activity.
    Kupferberg HJ; Yonekawa W
    Drug Metab Dispos; 1975; 3(1):26-9. PubMed ID: 234831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A search for new anticonvulsants among 3-aryl-5-benzylidene-derivatives of 2-thiohydantoin.
    Musial L; Korohoda MJ; Szadowska A; Szmigielska H
    Acta Pol Pharm; 1972; 29(6):569-77. PubMed ID: 4670132
    [No Abstract]   [Full Text] [Related]  

  • 46. [ACTION OF VARIOUS UREIDES ON K GRADIENTS OF MAMMALIAN CEREBRAL TISSUE ELECTRICALLY STIMULATED IN VITRO].
    CORRIOL J; JOANNY P; FONDARAI J
    C R Seances Soc Biol Fil; 1963; 157():2224-7. PubMed ID: 14137442
    [No Abstract]   [Full Text] [Related]  

  • 47. The effect of sodium dilantin administration upon the chemistry of the skin.
    HOUCK JC; JACOB RA; MAENGWYN-DAVIES GD
    J Clin Invest; 1960 Nov; 39(11):1758-62. PubMed ID: 13716128
    [No Abstract]   [Full Text] [Related]  

  • 48. Synthesis and search for anticonvulsive and hypoglycemic properties of novel 5-benzylidene derivatives of 3-o-chloro- and 3-o-methylbenzoyl-2-thiohydantoin.
    Kleinrok Z; Sermak W; Kozicka M
    Pol J Pharmacol Pharm; 1987; 39(3):237-44. PubMed ID: 3438210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The combined anticonvulsant activity and toxicity of dilantin and N-methyl-5-phenylsuccinimide.
    CHEN G; ENSOR CR
    J Lab Clin Med; 1953 Jan; 41(1):78-83. PubMed ID: 13023097
    [No Abstract]   [Full Text] [Related]  

  • 50. [Action of diphenylhydantoin, phenobarbital, trimethadione, and pentobarbital on Clementi's photic epilepsy in rabbit].
    MANTEGAZZINI P
    Arch Int Pharmacodyn Ther; 1956 Sep; 107(3-4):397-413. PubMed ID: 13363513
    [No Abstract]   [Full Text] [Related]  

  • 51. The prolongation of the anticonvulsant activity of 5,5 diphenylhydantoine in rats by partial hepatectomy.
    NASH JB; CLEMENTS R
    Arch Int Pharmacodyn Ther; 1952 May; 89(4):434-7. PubMed ID: 14953549
    [No Abstract]   [Full Text] [Related]  

  • 52. Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study.
    Thenmozhiyal JC; Wong PT; Chui WK
    J Med Chem; 2004 Mar; 47(6):1527-35. PubMed ID: 14998338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [EFFECT OF ANTICONVULSANT DRUGS ON HEMATOPOIESIS].
    DIESKA D; GAJDOS M
    Cas Lek Cesk; 1964 Aug; 103():961-5. PubMed ID: 14190563
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effects of acetazolamide and diphenylhydantoin on brain sodium and amino acid metabolism].
    PYLKKO OO; WOODBURY DM
    Duodecim; 1959; 75():867-73. PubMed ID: 14435416
    [No Abstract]   [Full Text] [Related]  

  • 55. Laboratory assay of anticonvulsant potency of some hydantoinates.
    SWINYARD EA; GOODMAN LS
    Fed Proc; 1946; 5(1 Pt 2):205. PubMed ID: 21064451
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of the anticonvulsant actions of some phenylhydantoins and their corresponding phenylacetylureas.
    SWINYARD EA; TOMAN JE
    J Pharmacol Exp Ther; 1950 Oct; 100(2):151-7. PubMed ID: 14784952
    [No Abstract]   [Full Text] [Related]  

  • 57. [METABOLISM AND COMPARATIVE EXCRETION OF SEVERAL ANTICONVULSANT DRUGS].
    GLASSON B; BENAKIS A; ERNST C
    Therapie; 1963; 18():1483-91. PubMed ID: 14117544
    [No Abstract]   [Full Text] [Related]  

  • 58. Convulsive thresholds and the activity of anticonvulsants in electroseizure test. The role of serotoninergic system.
    Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(2):143-55. PubMed ID: 934946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Metabolic study of an anticonvulsant labeled with radiocarbon: 4-C-14-3-methyl-5-ethylhydantoin].
    VIGNE JP; FONDARAI JA
    Pathol Biol; 1959 Jun; 7():1219-24. PubMed ID: 13842192
    [No Abstract]   [Full Text] [Related]  

  • 60. Anticonvulsant drug therapy of behavior problem children with abnormal electroencephalograms.
    PASAMANICK B
    AMA Arch Neurol Psychiatry; 1951 Jun; 65(6):752-66. PubMed ID: 14829105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.